|
PHKB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.198400E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.838400E-02 |
| Stage1-vs-Stage3 |
2.541500E-02 |
| Stage1-vs-Stage4 |
4.39859999999959E-05 |
| Stage2-vs-Stage3 |
2.704200E-03 |
| Stage2-vs-Stage4 |
1.026180E-04 |
| Stage3-vs-Stage4 |
6.167700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.05160000041238E-07 |
| Normal-vs-Asian |
1.72983849466846E-12 |
| Caucasian-vs-AfricanAmerican |
3.385600E-01 |
| Caucasian-vs-Asian |
6.083400E-01 |
| AfricanAmerican-vs-Asian |
2.554400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63058455626697E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.259800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.80109269112927E-13 |
| Normal-vs-Age(81-100Yrs) |
4.157900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.834600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.315200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.651600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.046600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.298400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.203100E-04 |
| Classical-VS-Follicular |
9.02390000501185E-08 |
| Classical-VS-Other |
8.562000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.58260079988304E-11 |
| Tall-VS-Other |
4.076800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.888200E-02 |
| Follicular-VS-Normal |
1.415610E-04 |
| Other-VS-Normal |
2.16799999999129E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68673971959288E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.81240000000282E-05 |
|
|
